181 related articles for article (PubMed ID: 25097078)
1. Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Med Oncol; 2014 Sep; 31(9):145. PubMed ID: 25097078
[TBL] [Abstract][Full Text] [Related]
2. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 125(3):715-27. PubMed ID: 20369284
[TBL] [Abstract][Full Text] [Related]
4. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Hao L; Zhang C; Qiu Y; Wang L; Luo Y; Jin M; Zhang Y; Guo TB; Matsushima K; Zhang Y
Cancer Lett; 2007 Aug; 253(1):34-42. PubMed ID: 17306924
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
[TBL] [Abstract][Full Text] [Related]
6. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
[TBL] [Abstract][Full Text] [Related]
7. [Downregulation of Duffy antigen receptor for chemokine (DARC) is associated with lymph node metastasis in human breast cancer].
Ou ZL; Wang J; Hou YF; Luo JM; Shen ZZ; Shao ZM
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):586-9. PubMed ID: 17236552
[TBL] [Abstract][Full Text] [Related]
8. The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer.
Lu CL; Ji Y; Ge D; Guo J; Ding JY
Dis Esophagus; 2011 May; 24(4):283-90. PubMed ID: 21087342
[TBL] [Abstract][Full Text] [Related]
9. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
Zheng SQ; Huang RQ; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
[TBL] [Abstract][Full Text] [Related]
10. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer.
Zhu Z; Sun Z; Wang Z; Guo P; Zheng X; Xu H
J Surg Res; 2013 Jul; 183(1):177-83. PubMed ID: 23462454
[TBL] [Abstract][Full Text] [Related]
12. Independent risk factors for axillary lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
Zhang W; Xu J; Wang K; Tang XJ; Liang H; He JJ
BMC Womens Health; 2020 Jul; 20(1):143. PubMed ID: 32646416
[TBL] [Abstract][Full Text] [Related]
13. Effect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancer.
Yang C; Yu KD; Xu WH; Chen AX; Fan L; Ou ZL; Shao ZM
PLoS One; 2013; 8(11):e78901. PubMed ID: 24260134
[TBL] [Abstract][Full Text] [Related]
14. Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization.
Takatsuka S; Sekiguchi A; Tokunaga M; Fujimoto A; Chiba J
J Pharmacol Toxicol Methods; 2011; 63(3):250-7. PubMed ID: 21184834
[TBL] [Abstract][Full Text] [Related]
15. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Wang Q; Diao X; Sun J; Chen Z
Urol Oncol; 2013 Apr; 31(3):312-7. PubMed ID: 21367627
[TBL] [Abstract][Full Text] [Related]
17. The clinical value of tumor FDG uptake for predicting axillary lymph node metastasis in breast cancer with clinically negative axillary lymph nodes.
Seok JW; Kim Y; An YS; Kim BS
Ann Nucl Med; 2013 Jul; 27(6):546-53. PubMed ID: 23543486
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer.
Jobim FC; Xavier NL; Uchoa DM; Cruz DB; Saciloto M; Chemello N; Schwartsmann G
Braz J Med Biol Res; 2009 Oct; 42(10):979-87. PubMed ID: 19787153
[TBL] [Abstract][Full Text] [Related]
20. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
